ALNY
Price
$266.07
Change
-$3.88 (-1.44%)
Updated
Nov 5, 04:50 PM (EDT)
93 days until earnings call
ARWR
Price
$20.44
Change
+$0.38 (+1.89%)
Updated
Nov 5, 04:52 PM (EDT)
20 days until earnings call
Ad is loading...

ALNY vs ARWR

Header iconALNY vs ARWR Comparison
Open Charts ALNY vs ARWRBanner chart's image
Alnylam Pharmaceuticals
Price$266.07
Change-$3.88 (-1.44%)
Volume$2.41K
CapitalizationN/A
Arrowhead Pharmaceuticals
Price$20.44
Change+$0.38 (+1.89%)
Volume$1.29K
CapitalizationN/A
View a ticker or compare two or three
ALNY vs ARWR Comparison Chart
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALNY vs. ARWR commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Buy and ARWR is a StrongSell.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ALNY: $269.93 vs. ARWR: $20.06)
Brand notoriety: ALNY: Not notable vs. ARWR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 90% vs. ARWR: 58%
Market capitalization -- ALNY: $34.82B vs. ARWR: $2.49B
ALNY [@Biotechnology] is valued at $34.82B. ARWR’s [@Biotechnology] market capitalization is $2.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileARWR’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • ARWR’s FA Score: 1 green, 4 red.
According to our system of comparison, ALNY is a better buy in the long-term than ARWR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while ARWR’s TA Score has 4 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 5 bearish.
  • ARWR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARWR is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а -5.92% price change this week, while ARWR (@Biotechnology) price change was -0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.26%. For the same industry, the average monthly price growth was +14.33%, and the average quarterly price growth was +9.93%.

Reported Earning Dates

ALNY is expected to report earnings on Feb 06, 2025.

ARWR is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (+4.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($34.8B) has a higher market cap than ARWR($2.49B). ALNY YTD gains are higher at: 41.022 vs. ARWR (-34.444). ALNY has higher annual earnings (EBITDA): -85.69M vs. ARWR (-508.26M). ALNY has more cash in the bank: 2.78B vs. ARWR (434M). ARWR has less debt than ALNY: ARWR (118M) vs ALNY (1.3B). ALNY has higher revenues than ARWR: ALNY (2.1B) vs ARWR (19.6M).
ALNYARWRALNY / ARWR
Capitalization34.8B2.49B1,395%
EBITDA-85.69M-508.26M17%
Gain YTD41.022-34.444-119%
P/E RatioN/AN/A-
Revenue2.1B19.6M10,689%
Total Cash2.78B434M641%
Total Debt1.3B118M1,103%
FUNDAMENTALS RATINGS
ALNY vs ARWR: Fundamental Ratings
ALNY
ARWR
OUTLOOK RATING
1..100
545
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
13100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3964
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARWR's Valuation (95) in the Biotechnology industry is in the same range as ALNY (99). This means that ARWR’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (13) in the Biotechnology industry is significantly better than the same rating for ARWR (100). This means that ALNY’s stock grew significantly faster than ARWR’s over the last 12 months.

ARWR's SMR Rating (98) in the Biotechnology industry is in the same range as ALNY (100). This means that ARWR’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Price Growth Rating (39) in the Biotechnology industry is in the same range as ARWR (64). This means that ALNY’s stock grew similarly to ARWR’s over the last 12 months.

ARWR's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for ALNY (100). This means that ARWR’s stock grew significantly faster than ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYARWR
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 21 days ago
77%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
67%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLPAX7.980.07
+0.88%
Invesco SteelPath MLP Alpha A
TRASX16.030.03
+0.19%
T. Rowe Price Asia Opportunities I
AASMX23.840.04
+0.17%
Thrivent Small Cap Stock A
MEIHX52.83-0.14
-0.26%
MFS Value R3
ARTLX15.39-0.06
-0.39%
Artisan Value Investor

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-1.45%
IONS - ALNY
44%
Loosely correlated
-0.88%
ATRA - ALNY
44%
Loosely correlated
+19.77%
SGMO - ALNY
42%
Loosely correlated
-7.45%
AMLX - ALNY
40%
Loosely correlated
+1.33%
VXRT - ALNY
40%
Loosely correlated
-5.83%
More

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+2.92%
NTLA - ARWR
51%
Loosely correlated
+2.30%
EDIT - ARWR
49%
Loosely correlated
-1.03%
BEAM - ARWR
48%
Loosely correlated
+6.24%
ALNY - ARWR
46%
Loosely correlated
-1.45%
AXON - ARWR
46%
Loosely correlated
+1.35%
More